AAAAAA

   
Results: 1-3 |
Results: 3
Pharmacokinetic drug interaction potential of risperidone with cytochrome P450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test
Authors: Eap, CB Bondolfi, G Zullino, D Bryois, C Fuciec, M Savary, L Jonzier-Perey, M Baumann, P
Citation: Cb. Eap et al., Pharmacokinetic drug interaction potential of risperidone with cytochrome P450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test, THER DRUG M, 23(3), 2001, pp. 228-231
Pharmacokinetic consequences of a citalopram treatment discontinuation (vol 21, pg 263, 1999)
Authors: Voirol, P Rubin, C Bryois, C Kosel, M Buclin, T Baumann, P
Citation: P. Voirol et al., Pharmacokinetic consequences of a citalopram treatment discontinuation (vol 21, pg 263, 1999), THER DRUG M, 21(6), 1999, pp. 682-682
Pharmacokinetic consequences of a citalopram treatment discontinuation
Authors: Voirol, P Rubin, C Bryois, C Kosel, M Buclin, T Baumann, P
Citation: P. Voirol et al., Pharmacokinetic consequences of a citalopram treatment discontinuation, THER DRUG M, 21(3), 1999, pp. 263-266
Risultati: 1-3 |